Page 9 - Yannick Tetzlaff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yannick tetzlaff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yannick Tetzlaff Today - Breaking & Trending Today

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to NASH resolution and fibrosis improvemen


University,

The need to develop reliable NASH biomarkers is both clear and urgent as the utility of liver biopsy, the only diagnostic approach currently available, is limited due to its invasive nature, poor patient acceptability and sampling variability. So we are very much looking
forward to working with Inventiva on lanifibranor, a drug candidate that has shown very promising results in the field of NASH. Given the efficacy shown by lanifibranor during the NATIVE Phase IIb trial and the promising biomarker dataset available, we are confident that we will be able to meet our objective to develop
one or several robust biomarkers or composite biomarker score ....

United States , Yannick Tetzlaff , Aude Lepreux , Pierre Broqua , Patricial Bank , Brunswick Group , Department Of Hepato , Anna Mae Diehl Lab Of Duke University , Faculty Of Medicine Angers University , Digestive Oncology At Angers University Hospital , Hangers University , Euronext Paris , Liver Meeting Digital Experience , Non Alcoholic Fatty Liver Disease , Professor Boursier , Digestive Oncology , Anna Mae Diehl Lab , Duke University , Breakthrough Therapy , Fast Track , Nasdaq Global Market , Roquet Montegon , Universal Registration Document , Des March , Interaction Fibrose , Fibrosis Interaction ,

INVENTIVA: Inventiva to participate at several investor conferences in March 2021


INVENTIVA: Inventiva to participate at several investor conferences in March 2021
Daix
(France), February 24, 2021 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that Frédéric Cren, Chairman, CEO and cofounder of Inventiva, will participate at three upcoming investor conferences in March 2021.
The event details are as follows:
Conference n°1: Credit Suisse Virtual 2021 London Global Healthcare Conference
Event type: One-on-one investor meetings
Date: Tuesday-Thursday, March 2-4, 2021
Format: Virtual event
Event type: Corporate presentation, fireside chat, one-on-one investor meetings ....

City Of , United Kingdom , Yannick Tetzlaff , Aude Lepreux , Patricial Bank , Brunswick Group , Euronext Paris , Suisse Virtual , Global Healthcare , Virtual Global Life Sciences , Virtual Annual Roth , Breakthrough Therapy , Fast Track , Roquet Montegon , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , பிரன்சுவிக் குழு , ஸ்யூயி மெய்நிகர் , உலகளாவிய சுகாதாரம் , மெய்நிகர் உலகளாவிய வாழ்க்கை அறிவியல் , மெய்நிகர் ஆண்டு ரோத் , திருப்புமுனை சிகிச்சை , வேகமாக டிராக் ,